Bone Mineral Density, TBS, and Body Composition Indexes in Ukrainian Men with Parkinson’s Disease

by Vladyslav Povoroznyuk, Maryna Bystrytska, Nataliia Grygorieva, Iryna Karaban, Nina Karasevich
Published 2019-01-01

Dietary Variations in a Multiethnic Parkinson’s Disease Cohort and Possible Influences on Nonmotor Aspects: A Cross-Sectional Multicentre Study

by Anna Sauerbier, Anette Schrag, Pablo Martinez-Martin, Lynsey J. Hall, Miriam Parry, Laurie K. Mischley, Panagiotis Zis, K. Ray Chaudhuri
Published 2018-01-01

Neuroinflammation and Myelin Status in Alzheimer’s Disease, Parkinson’s Disease, and Normal Aging Brains: A Small Sample Study

by Fei Han, Richard J. Perrin, Qing Wang, Yong Wang, Joel S. Perlmutter, John C. Morris, Tammie L. S. Benzinger, Jinbin Xu
Published 2019-01-01

5-HT2A Receptor Binding in the Frontal Cortex of Parkinson’s Disease Patients and Alpha-Synuclein Overexpressing Mice: A Postmortem Study

by Nadja Bredo Rasmussen, Mikkel Vestergaard Olesen, Tomasz Brudek, Per Plenge, Anders Bue Klein, Jenny E. Westin, Karina Fog, Gitta Wörtwein, Susana Aznar
Published 2016-01-01

MRI Correlates of Parkinson’s Disease Progression: A Voxel Based Morphometry Study

by Valentina Fioravanti, Francesca Benuzzi, Luca Codeluppi, Sara Contardi, Francesco Cavallieri, Paolo Nichelli, Franco Valzania
Published 2015-01-01

Colonic Oxidative and Mitochondrial Function in Parkinson’s Disease and Idiopathic REM Sleep Behavior Disorder

by C. Morén, Í. González-Casacuberta, J. Navarro-Otano, D. Juárez-Flores, D. Vilas, G. Garrabou, J. C. Milisenda, C. Pont-Sunyer, M. Catalán-García, M. Guitart-Mampel, E. Tobías, F. Cardellach, F. Valldeoriola, A. Iranzo, E. Tolosa
Published 2017-01-01

The rs13388259 Intergenic Polymorphism in the Genomic Context of the BCYRN1 Gene Is Associated with Parkinson’s Disease in the Hungarian Population

by Sándor Márki, Anikó Göblös, Eszter Szlávicz, Nóra Török, Péter Balicza, Benjamin Bereznai, Annamária Takáts, József Engelhardt, Péter Klivényi, László Vécsei, Mária Judit Molnár, Nikoletta Nagy, Márta Széll
Published 2018-01-01

Stress Management Training (SMT) Improves Coping of Tremor-Boosting Psychosocial Stressors and Depression in Patients with Parkinson’s Disease: A Controlled Prospective Study

by C. Buhmann, D. Jungnickel, E. Lehmann
Published 2018-01-01

Cortical Visual Performance Test Setup for Parkinson’s Disease Based on Motion Blur Orientation

by M. Erdem Isenkul
Published 2019-01-01

Reliability in One-Repetition Maximum Performance in People with Parkinson's Disease

by Thomas A. Buckley, Christopher J. Hass
Published 2012-01-01

The Association between DRD3 Ser9Gly Polymorphism and Depression Severity in Parkinson’s Disease

by Yan Zhi, Yongsheng Yuan, Qianqian Si, Min Wang, Yuting Shen, Lina Wang, Hui Zhang, Kezhong Zhang
Published 2019-01-01

Feasibility and Acceptability of Computerised Cognitive Training of Everyday Cognition in Parkinson’s Disease

by S. J. Smith, I. McMillan, I. Leroi, C. L. Champ, S. Barr, K. R. McDonald, J. P. R. Dick, E. Poliakoff
Published 2019-01-01

Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson’s Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

by Kazunori Sato, Noriaki Aita, Yoshihide Hokari, Eriko Kitahara, Mami Tani, Nana Izawa, Kozo Hatori, Ryota Nakamura, Fuyuko Sasaki, Satoko Sekimoto, Takayuki Jo, Genko Oyama, Taku Hatano, Yasushi Shimo, Hirokazu Iwamuro, Atsushi Umemura, Nobutaka Hattori, Toshiyuki Fujiwara
Published 2019-01-01

Camptocormia in Parkinson's Disease

by Kazuo Abe, Yutaka Uchida, Masaru Notani
Published 2010-01-01

Subjective Vertical Position Allows Prediction of Postural Deterioration in Patients with Parkinson’s Disease

by Kyohei Mikami, Makoto Shiraishi, Tsutomu Kamo
Published 2019-01-01

Living with Parkinson’s and the Emerging Role of Occupational Therapy

by Jelka Jansa, Ana Aragon
Published 2015-01-01

Salivary Acetylcholinesterase Activity Is Increased in Parkinson’s Disease: A Potential Marker of Parasympathetic Dysfunction

by Tatyana Fedorova, Cindy Soendersoe Knudsen, Kim Mouridsen, Ebba Nexo, Per Borghammer
Published 2015-01-01

Sensitivity and Specificity of the ECAS in Parkinson’s Disease and Progressive Supranuclear Palsy

by Jennifer A. Foley, Elaine H. Niven, Andrew Paget, Kailash P. Bhatia, Simon F. Farmer, Paul R. Jarman, Patricia Limousin, Thomas T. Warner, Huw R. Morris, Thomas H. Bak, Sharon Abrahams, Lisa Cipolotti
Published 2018-01-01

Uncovering Indicators of the International Classification of Functioning, Disability, and Health from the 39-Item Parkinson's Disease Questionnaire

by Maria H. Nilsson, Albert Westergren, Gunilla Carlsson, Peter Hagell
Published 2010-01-01

Magnolol Protects against MPTP/MPP+-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson’s Disease

by Akiko Muroyama, Aya Fujita, Cheng Lv, Shota Kobayashi, Yoshiyasu Fukuyama, Yasuhide Mitsumoto
Published 2012-01-01